- Start
- Sep 29, 202590% CONFIDENCEfrom the source
GSK Names Luke Miels CEO Designate to Succeed Emma Walmsley
- GSK announced that Luke Miels, its Chief Commercial Officer since joining in 2017, is appointed CEO Designate and will assume full responsibilities as CEO and join the board on 1 January 2026[1]
- He will succeed Dame Emma Walmsley, who the release says delivered a step-change in operating performance and created Haleon; GSK now targets total sales of more than GBP 40 billion by 2031[1]
- Before GSK, Miels worked at senior levels at AstraZeneca, Roche and Sanofi-Aventis, and the board considered both internal and external candidates[1]
- Walmsley said 2026 is 'a pivotal year for GSK' and the right moment for new leadership; Indian Pharma Post reported the announcement came on Monday 29 September[1][3]
References 481% CONFIDENCEOverall confidence: 81%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better
The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.
- [1]90%gsk.com/en-gb/media/press-releases/luke-miels-appointed-ceo-designate-for-gskgsk.com· Posted Oct 4, 2026· Starts Sep 29, 2025 ✓· 40% of score
The GSK release is undated in its text, but the Indian Pharma Post[3] story (30 September 2025) says GSK named Miels 'on Monday' and Medical Dialogues[4] is dated 29 September 2025, a Monday.
- [2]75%GSK's Emma Walmsley to step down as CEO - European Pharmaceutical Revieweuropeanpharmaceuticalreview.com· Added Oct 4, 2026· 40% of score
Trade-press report of the succession.[1]
- [3]75%GSK names Luke Miels as next CEO - Indian Pharma Postindianpharmapost.com· Published Sep 30, 2025· 10% of score
States the Monday announcement and the 1 January 2026 start.[1]
- [4]75%GSK appoints Luke Miels as CEO designate - Medical Dialoguesmedicaldialogues.in· Published Sep 29, 2025· 10% of score
Dated 29 September 2025.[1]
Suggest a correction
Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most. A picture that shows something else, or shows it badly, is looked at too, and moved down or replaced.
Berkshire Hathaway
